Risedronate Sodium for the Treatment of Osteoporosis and Paget’s Disease: The Evidence of its Therapeutic Value

Abstract

Risedronate is a third generation bisphosphonate used in the prevention of osteoporotic fractures and the treatment of Paget’s disease. In patients with osteoporosis, risedronate reduces bone turnover, improves bone density and reduces the risk of both vertebral and non-vertebral fractures. Efficacy has been established in the treatment of postmenopausal… (More)

Topics

1 Figure or Table

Cite this paper

@inproceedings{Center2012RisedronateSF, title={Risedronate Sodium for the Treatment of Osteoporosis and Paget’s Disease: The Evidence of its Therapeutic Value}, author={Jacqueline R. Center}, year={2012} }